At the news
? NEUTRALIMPACT 2/10 144 filed Nov 12, 2026 at 16:00 ET
Mark Sabag, EVP of International Markets Commercial at Teva, filed a Form 144 notice of intent to sell 44,710 ordinary shares valued at approximately $1.97M. The sale is tied to a stock option exercise and represents a routine insider transaction for compensation purposes.
- Mark Sabag (EVP International Markets Commercial) filed Form 144 to sell 44,710 ordinary shares
- Estimated aggregate value of the proposed sale is $1,973,545.81
- Sale is related to a stock option exercise and compensation
- Broker for the sale is Citigroup Global Markets Inc.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access